A program of the Eye and Ear Foundation, the Pittsburgh Collaborative Research, Education, And Technology Enhancement in Surgery (CREATES), is a trans-disciplinary research and education collaboration, housing all aspects of unique surgical innovation.  The initial focus is to improve minimally invasive technology to treat patients with head and neck tumors, given Pitt’s expertise and current demand for such specific knowledge and research.  

The Clinical and Translational Science Institute (CTSI) at the University of Pittsburgh is an integral part of a National Institutes of Health (NIH)-funded nationwide network whose charge is to speed new treatments to the people who need them. CTSI provides the support necessary to bridge the gap between innovative approaches to research and effective clinical and public health practice, health policy, and community engagement in research.


The mission of the University of Pittsburgh Center for Medical Innovation (CMI) is two-fold: (1) Promote the research and development of innovative biomedical technologies to solve clinical problems.  This is accomplished by facilitating clinician-engineer (basic scientist)-student interactions and providing seed funding for early-stage work.  In partnership with the Coulter Translational Research Partners II Program, Innovation Institute, and the Clinical and Translational Science Institute, CMI facilitates the translation of these early-stage innovative biomedical technologies into marketable products and services.  (2) Educate the next generation of innovators by offering degree-granting or certificate programs in medical product engineering and medical product innovation.  These educational programs are offered through the Department of Bioengineering in the Swanson School of Engineering, in cooperation with the Katz Graduate School of Business and the Schools of the Health Sciences and Law. 


The University’s Institute for Precision Medicine facilitates the movement of biomedical research into personalized clinical care.  The over-arching goal is to help researchers and clinicians discover and exploit clinically actionable individual features about risk of disease, optimal treatment, disease course, and response to treatment. There are significant opportunities to collaborate with industry and take advantage of Pittsburgh’s unique assets which bring together Pitt’s translational research in the field, CMU’s expertise in computing and big data, and UPMC as the largest academic payer-provider in the US.


Established in 2013, The University of Pittsburgh Innovation Institute is the University’s hub for innovation and entrepreneurship.

The Innovation Institute provides a comprehensive suite of services for Pitt Innovators, from protecting intellectual property to the commercialization of new discoveries through licensing and/or new enterprise development. The Institute also provides a wealth of educational programming, mentoring and networking for Pitt faculty, students, and partners.

The Innovation Institute is strengthening the culture of innovation and entrepreneurship at Pitt supporting entrepreneurial initiatives across the university. It is also invites alumni, entrepreneurs and industry partners to collaborate with Pitt faculty and students to help achieve societal impact through commercialization.

Through the affiliated Institute for Entrepreneurial Excellence, the Innovation Institute also assists entrepreneurs throughout Western Pennsylvania in starting, growing or transitioning their businesses.

The McGowan Institute for Regenerative Medicine focuses on the development of technology to address tissue and organ insufficiency. Serving as a single base of operations for the University’s leading scientists and clinical faculty working to develop tissue engineering, cellular therapies, and artificial and biohybrid organ devices, the Institute’s mission includes the development of innovative clinical protocols as well as the pursuit of rapid commercial transfer of its technologies related to regenerative medicine.

A University of Pittsburgh program born from the Schools of Health Sciences and Department of Bioengineering that accelerates life sciences academic commercial translation. sciVelo adds value by bringing teams of scientists and business experts that have experience in all phases of the commercial development process.

The Coulter Translational Research Partners II Program is a University based accelerator, designed to help faculty researchers translate their innovations to commercialization.  The Program aims to identify, select, and develop promising late-stage biomedical projects that address significant unmet clinical needs and have the potential for positive clinical and economic impacts.  By way of a competitive grant program, training processes, and collaborative services, our goal is to de-risk University technology and identify viable commercial pathways through the complex healthcare industry landscape.    Further, we engage extensively with business partners, mentors and clinical experts to bring industry perspectives to translational research.  The Program is a partnership between the Swanson School of Engineering's Department of Bioengineering, University of Pittsburgh School of Medicine and the Innovation Institute.